Sucampo Pharmaceuticals (0LAE)

Company name:	Sucampo Pharmaceuticals Inc
EPIC:	0LAE	Trading Currency:	USD
Market Sector:	SXEL	ISIN:
Market Segment:	SSX4	Share Type:	DE
WWW Address:		Description:	SUCAMPO PHARMACEUTICALS ORD SHS CLASS A
Industry Sector:

Sucampo Pharmaceuticals Key Figures

(at previous day's close)
Market Cap.	-	m
Shares In Issue	-	m
Prev. Close	18.00
PE Ratio	-
Dividend Yield	-	%
EPS - basic	-	¢($)
Dividend PS	-	¢($)
Dividend Cover	-
Cash Flow PS	-	¢($)
Return On Equity (ROE)	-	%
Operating Margin	-	%
PEG Factor	-
EPS Growth Rate	-	%
Dividends PS Growth Rate	-	%
Net Debt	-	m
Gross Gearing	-	%
Quick Assets	-	m
Net Working Capital	-	m
Intangibles / Fixed Assets	-	%
Turnover PS	-	¢($)
Pre-Tax Profit PS	-	¢($)
Retained Profit PS	-	¢($)
Cash PS	-	¢($)
Net Cash PS	-	¢($)
Net Tangible Asset Value PS *	-	¢($)
Net Asset Value PS	-	¢($)
Spread	- (-%)
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Sorry No Data Available

Sorry No Data Available

Sorry No Data Available

(Market value analysis) at previous day's close
PQ Ratio	-
PE Ratio	-
Tobin's Q Ratio	-
Tobin's Q Ratio (excl. intangibles)	-
Dividend Yield	-	%
Market-to-Book Ratio	-
Price-to-Pre-Tax Profit PS	-
Price-to-Retained Profit PS	-
Price-to-Cash Flow PS	-
Price-to-Sales PS	-
Price-to-Net Tangible Asset Value PS	-
Price-to-Cash PS	-
Net Working Capital PS	-
Price Pct to Working Capital PS	-	%
Earnings Yield	-	%
Average PE	-
Years in average	-
PE to PE average	-	%

(Leverage Ratios)
Debt Ratio	-	%
Debt-to-Equity Ratio	-
Debt-to-Equity Ratio (excl. Intgbl)	-
Debt-to-Equity Market Value	-
Net Gearing	-	%
Net Gearing (excl. Intangibles)	-	%
Gross Gearing	-	%
Gross Gearing (excl. Intangibles)	-	%
Gearing Under 1 Year	-	%
Gearing Under 1 Year (excl. Intgbl)	-	%
Assets/Equity	-
Cash/Equity	-
(Liquidity Ratios)
Net Working Capital to Total Assets	-	%
Current Ratio	-
Quick Ratio (Acid Test)	-
Liquidity Ratio	-
Cash & Equiv/Current Assets	-	%
(Solvency Ratios)
Enterprise Value	-	m
CFO/Sales	-
CFO/Attributable Profit	-
CFO/Assets	-
CFO/Debt	-
Total Debt/Equity Market Value	-
Total Debt/Sales	-
Total Debt/Pre-Tax Profit	-
Total Debt	-	m
Total Debt/Net Current Assets	-	%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth	-	%
5 yr Compound Earnings Growth	-	%
10 yr Compound Earnings Growth	-	%
Earn drops > 5% in 10yrs	-

Beta (60-Mnth)	Beta (36-Mnth)
-0.0000	-0.0000

(Profitability Ratios)
Return On Capital Employed (ROCE)	-	%
Return On Assets (ROA)	-	%
Net Profit Margin	-	%
Assets Turnover	-
Return On Equity (ROE)	-	%
Return On Investment (ROI)	-	%
Dividend Payout Ratio	-	%
Plowback Ratio	100.00	%
Growth from Plowback Ratio	-	%
Net Income Of Revenues	-	%
(Asset Utilisation Multiples)
Shareholders Equity Turnover	-
Fixed Assets Turnover	-
Current Assets Turnover	-
Net Working Capital Turnover
Inventory Turnover	-
(Other Operating Ratios)
Total Assets-to-Sales	-
Debtors-to-Sales	-	%
Debt Collection Period	-	Days

Sorry No Data Available

Sorry No Data Available

Sorry No Data Available

Sorry No Data Available

Broker infomation is not available for this class of stock.